DRP
ABCL icon

Decker Retirement Planning’s AbCellera Biologics ABCL Stock Holding History

Decker Retirement Planning’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Buy
+336,112
New +$1.64M 0.9% 30

Other funds holding ABCL

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM

Decker Retirement Planning's ABCL Position: Q2 2026 in Review

Decker Retirement Planning opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 336,112 shares worth $2.64M. The stake represents 0.9% of the portfolio and ranks #30 among its holdings.

6 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Decker Retirement Planning held 336,112 shares of AbCellera Biologics worth $2.64M as of Q2 2026.
  • AbCellera Biologics was a new Decker Retirement Planning position in Q2 2026.
  • AbCellera Biologics made up 0.9% of Decker Retirement Planning's portfolio in Q2 2026, its #30 holding.
  • 6 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.